Key result
Systemic lupus erythematosus is linked to accelerated atherosclerosis with up to ~45% myocardial infarction prevalence.
Answers are grounded in this paper and cite their sources.
Confirms accelerated atherosclerosis and elevated myocardial infarction risk in systemic lupus erythematosus, highlighting the clinical importance of cardiovascular risk factors.
An association between accelerated atherosclerosis and systemic lupus erythematosus (SLE), typified by the occurrence of a myocardial infarction in a 30-year-old woman who had had the disease for more than 10 years, was suggested in 1976.1 The two studies by Roman et al. (pages 2399–2406) and Asanuma et al. (pages 2407–2415) in this issue of the Journal confirm this association and provide important information regarding risk factors. The reported prevalence of myocardial infarcts in patients with SLE ranges from 4 percent to 45 percent, with studies of surrogate markers providing support for the higher figure. For example, in one study . . .
No takes yet. Share an insight, caveat, or question.
Bevra H. Hahn (2003) conducted an editorial in Systemic lupus erythematosus and accelerated atherosclerosis. Systemic lupus erythematosus was evaluated on Myocardial infarction and accelerated atherosclerosis. Systemic lupus erythematosus is associated with accelerated atherosclerosis, with a reported myocardial infarction prevalence ranging from 4% to 45%.
Synapse has enriched 10 related papers. Consider them for comparative context: